Stanley Scott Cancer Center, Louisiana State Health Sciences Center and Louisiana Cancer Research Consortium, New Orleans, LA 70112, USA.
Correspondence Address: Prof. Lucio Miele, Stanley Scott Cancer Center, Louisiana State Health Sciences Center and Louisiana Cancer Research Consortium, New Orleans, LA 70112, USA. E-mail: lmiele@lsuhsc.edu
Received: 11 Jun 2015 | Accepted: 18 Jun 2015 | Published: 15 Jul 2015
It is my privilege to introduce the second issue of the Journal of Cancer Metastasis and Treatment. In keeping with the format we have chosen for our journal, this issue contains two reviews focusing on fields of great translational and clinical interest, five original articles, and three case reports. The first review discusses the rapidly evolving field of circulating tumor cells (CTC) as cancer biomarkers. Since the introduction of the first Food and Drug Administration approved CTC test to assess the progression of metastatic breast, colorectal and prostate cancer, CTC have generated tremendous interest among clinicians seeking sensitive progression biomarkers and basic scientists interested in isolating and studying these cells. A number of new sorting, capture, and enumeration technologies are being evaluated. Competing technologies have emerged, such as circulating tumor DNA. The review by Potdar and Lotey summarizes the current experience with CTC as diagnostic and prognostic biomarkers and the future of this technology. The review by Alfonso et al. describes recent progress in our understanding of urothelial cancer, a poorly understood malignancy that can be very difficult to treat, based on novel translational science. The original articles cover a variety of translational and clinical topics: the rapidly growing field of extracellular microRNA (miRNA) detection and quantification, as applied to medulloblastoma; the management of diffuse large B-cell non-Hodgkin lymphoma (NHL) in elderly Egyptian patients; the prognostic value of GATA3 and FOXA1 detection in breast cancer; current clinical criteria for the management of squamous non-small cell lung cancer (NSCLC); and the pharmacological properties of Withania somnifera extract in a triple-negative breast cancer model. miRNAs and other non-coding RNAs in biological fluids promise to revolutionize the world of biomarkers. However, there remain significant technical issues surrounding the reproducible quantification of miRNAs for clinical purposes. The manuscript by Shalaby et al. is an example of progress in this highly promising field. The manuscript by Zeeneldin et al. describes the experience of treating diffuse large B-cell NHL in a geriatric setting where safety and efficacy considerations have be balanced against each other and where monoclonal antibodies are not always available. The study by Chivukula et al. proposes the intriguing hypothesis that immunohistochemical detection of the transcription factor GATA3 and “pioneer” factor FOXA1 has prognostic value in breast cancer. The manuscript by Savini et al. describes the experience of this group treating squamous NSCLC, analyzing variables associated with improved survival in their patient population. The article by Ray et al. describes the effect of a promising natural product, an extract from well-known medicinal plant Withania somnifera, on the production of cytokines associated with metastasis in a standard triple-negative breast cancer model. Finally, the three case reports describe unusual presentations, including histologically different metastases from an unknown primary lesion, orbital metastasis from rectal carcinoma and a mature spinal teratoma presenting in an elderly patient.
I hope you enjoy reading this issue, and the ones that will follow.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
Cite This Article
Editorial
Open Access
Introduction to Volume 1 Issue 2 of Journal of Cancer Metastasis and Treatment
Lucio Miele
How to Cite
Miele L. Introduction to Volume 1 Issue 2 of Journal of Cancer Metastasis and Treatment. J Cancer Metastasis Treat. 2015;1:43. http://dx.doi.org/10.4103/2394-4722.160150
Download Citation
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click on download.
Export Citation File:
Type of Import
Tips on Downloading Citation
This feature enables you to download the bibliographic information (also called citation data, header data, or metadata) for the articles on our site.
Citation Manager File Format
Use the radio buttons to choose how to format the bibliographic data you're harvesting. Several citation manager formats are available, including EndNote and BibTex.
Type of Import
If you have citation management software installed on your computer your Web browser should be able to import metadata directly into your reference database.
Direct Import: When the Direct Import option is selected (the default state), a dialogue box will give you the option to Save or Open the downloaded citation data. Choosing Open will either launch your citation manager or give you a choice of applications with which to use the metadata. The Save option saves the file locally for later use.
Indirect Import: When the Indirect Import option is selected, the metadata is displayed and may be copied and pasted as needed.
About This Article
Copyright
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which allows others to remix, tweak and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Comments must be written in English. Spam, offensive content, impersonation, and private information will not be permitted. If any
comment is reported and identified as inappropriate content by OAE staff, the comment will be removed without notice. If you have any
queries or need any help, please contact us at
support@oaepublish.com.
Comments
Comments must be written in English. Spam, offensive content, impersonation, and private information will not be permitted. If any comment is reported and identified as inappropriate content by OAE staff, the comment will be removed without notice. If you have any queries or need any help, please contact us at support@oaepublish.com.